“Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients”. 2018. Asian Journal of Pharmaceutics (AJP) 12 (03). https://doi.org/10.22377/ajp.v12i03.2653.